Peter said...
The sort of things I think are more advocacy topics than support topics are things like the AUA guidelines for PSA testing. Those are guidelines for urologists and, while it is fine for us to huddle up and form an opinion it is silly to waste thread after thread arguing about it.
It matters to some people more than it apparently matters to you. It's not a waste to them and there's no cost to the bandwidth, so if they want to argue -- what's the harm, as long as it's civil?
Peter said...
I also would like to banish the subject of "over-treatment" as understood by the AUA guidelines committee since it is a pure abstraction that by its nature cannot be applied to any individual, only to populations.
Its manifestation in the support world is due diligence in helping men looking at treatment options make an informed decision based on their risks and benefits. There was a question on the forum -- a survey, actually -- that asked "were you over-treated" and nobody recognized it as a trick question. The concept of over-treatment applies only to populations and it cannot ever be decided on an individual-by-individual basis.
I very much agree about
the applicability of research statistics to populations rather than to individuals. But isn't that a good thing to discuss? Not everyone has the background you do to understand that. Probabilities do enter into our decisions. Discussing the AUA (or NCCN, etc.) evaluation of the available research, its implications for our decisions, and the factors that we might want to take into consideration that may be exceptional to their evaluation are all important to men facing those decisions for themselves.
Peter said...
It is interesting as the philosophical/statistical basis for for some otherwise hard-to-understand guidelines that our doctors should consider in treating us but our role in reducing over-treatment is to support men one-at-a-time as they make their decisions and try to show the industry less appalling statistics going forward.
I don't think it's just
interesting, I think it's vital, whether we agree or disagree with their inferences. When an august organization like the AUA or ASTRO or NCCN, etc., takes a position on any aspect of prostate cancer, it should get our notice. Their imprimatur -- since they represent some of the most accomplished and experienced doctors in the country -- means a lot. I know I want to understand it fully even if I decide that I want to go in a different treatment or diagnostic direction in my own case. I would not like to see this relegated to the backwaters of the forum.
Peter said...
In support you are talking to, among, or within the patient community. In advocacy you are speaking about, for, and from them. In one you are telling them what they need to know to deal with their disease -- which can be as nerdy as you like -- in the other your are asking their opinions about larger conversations.
I understand the distinction you are making, but I don't think it works in practice. Those "larger conversations" intimately affect us -- we are the objects of those conversations, and they become part of what we need to know in our conversations with our doctors. I think we are just too involved to be able to have an abstract conversation about
those issues.
- Allen